Cynthia W. Hu

Cynthia W. Hu, listed as senior executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in CASI Pharmaceuticals, Inc. and Definium Therapeutics, Inc. Between 1 May 2012 and 24 March 2022, the trades on record add up to 8 filings.

Every open-market trade on record is a purchase: 5 purchases worth €11k, and no sale. The amount is not disclosed for 1 filing. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 2 share grants and 1 option exercise.

Half of the purchases are above €1,511 and half below. On 4 out of 4 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.

On 28 March 2022 came the latest disclosure, a share grant in Definium Therapeutics, Inc. The latest purchase dates back some time: it was published 3,945 days ago, on 21 January 2016. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.